Terms: = Ovarian cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Prognosis
21 results:
1. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
Němejcová K; Šafanda A; Bártů MK; Michálková R; Drozenová J; Fabian P; Hausnerová J; Laco J; Matěj R; Méhes G; Škapa P; Stružinská I; Dundr P
Diagn Pathol; 2023 Feb; 18(1):32. PubMed ID: 36855066
[TBL] [Abstract] [Full Text] [Related]
2. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Approach to Neuroendocrine Neoplasm Associated With ovarian Teratoma.
Opalińska M; Sowa-Staszczak A; Olearska H; Ulatowska-Bialas M; Gilis-Januszewska A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2021; 12():770266. PubMed ID: 34917031
[TBL] [Abstract] [Full Text] [Related]
4. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
5. Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?
Nasioudis D; Albright BB; Ko EM; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Latif NA
Arch Gynecol Obstet; 2020 Apr; 301(4):1047-1054. PubMed ID: 32185553
[TBL] [Abstract] [Full Text] [Related]
6. The Frequency and Prognostic Significance of the Histologic Type in Early-stage ovarian Carcinoma: A Reclassification Study by the Spanish Group for ovarian cancer Research (GEICO).
Leskela S; Romero I; Cristobal E; Pérez-Mies B; Rosa-Rosa JM; Gutierrez-Pecharroman A; Santón A; Gonzalez BO; López-Reig R; Hardisson D; Vera-Sempere F; Illueca C; Vieites B; López-Guerrero JA; Palacios J; Poveda A
Am J Surg Pathol; 2020 Feb; 44(2):149-161. PubMed ID: 31498173
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear β-catenin and cdx2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
Wang L; Rambau PF; Kelemen LE; Anglesio MS; Leung S; Talhouk A; Köbel M
Histopathology; 2019 Feb; 74(3):452-462. PubMed ID: 30326146
[TBL] [Abstract] [Full Text] [Related]
8. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract] [Full Text] [Related]
9. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
[TBL] [Abstract] [Full Text] [Related]
10. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
[TBL] [Abstract] [Full Text] [Related]
11. Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in cancer.
Begik O; Oyken M; Cinkilli Alican T; Can T; Erson-Bensan AE
Neoplasia; 2017 Jul; 19(7):574-582. PubMed ID: 28624626
[TBL] [Abstract] [Full Text] [Related]
12. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012.
Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD
Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024
[TBL] [Abstract] [Full Text] [Related]
13. [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].
Lax S; Staebler A
Pathologe; 2014 Jul; 35(4):327-35. PubMed ID: 24962632
[TBL] [Abstract] [Full Text] [Related]
14. Dyspnoea and the ovaries: a rare presentation of Krukenberg tumour.
Rawasia WF; Chaddha U; El-Kersh K; Perez RL
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23378553
[TBL] [Abstract] [Full Text] [Related]
15. Up-regulation of cadherin 17 and down-regulation of homeodomain protein cdx2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
Huang LP; Yu YH; Sheng C; Wang SH
Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
[TBL] [Abstract] [Full Text] [Related]
16. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
[TBL] [Abstract] [Full Text] [Related]
17. CK7, CK20, cdx2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
[TBL] [Abstract] [Full Text] [Related]
18. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
[TBL] [Abstract] [Full Text] [Related]
19. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
[TBL] [Abstract] [Full Text] [Related]
20. Expression of the intestinal marker cdx2 in secondary adenocarcinomas of the colorectum.
Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
[TBL] [Abstract] [Full Text] [Related]
[Next]
